Cargando…

Portal vein thrombosis; risk factors, clinical presentation and treatment

BACKGROUND: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse. The aim of this retrospective study was to describe risk factors, clinical presentation, complications and treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sogaard, Kirstine K, Astrup, Lone B, Vilstrup, Hendrik, Gronbaek, Henning
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976099/
https://www.ncbi.nlm.nih.gov/pubmed/17697371
http://dx.doi.org/10.1186/1471-230X-7-34
_version_ 1782135062310944768
author Sogaard, Kirstine K
Astrup, Lone B
Vilstrup, Hendrik
Gronbaek, Henning
author_facet Sogaard, Kirstine K
Astrup, Lone B
Vilstrup, Hendrik
Gronbaek, Henning
author_sort Sogaard, Kirstine K
collection PubMed
description BACKGROUND: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse. The aim of this retrospective study was to describe risk factors, clinical presentation, complications and treatment of portal vein thrombosis in a single-centre. METHODS: Sixty-seven patients were identified in the electronic records from 1992 to 2005. All data were obtained from the patient records. RESULTS: One or more risk factors (e.g. prothrombotic disorder or abdominal inflammation) were present in 87%. Symptoms were abdominalia, splenomegaly, fever, ascites, haematemesis, and weight loss. Abdominalia and fever occurred more frequently in patients with acute PVT. Frequent complications were splenomegaly, oesophageal- and gastric varices with or without bleeding, portal hypertensive gastropathy and ascites. Varices and bleeding were more frequent in patients with chronic PVT. Patients who received anticoagulant therapy more frequently achieved partial/complete recanalization. Patients with varices who were treated endoscopically in combination with β-blockade had regression of the varices. The overall mortality was 13% in one year, and was dependent on underlying causes. CONCLUSION: Most patients had a combination of local and systemic risk factors for PVT. We observed that partial/complete recanalization was more frequent in patients treated with anticoagulation therapy, and that regression of varices was more pronounced in patients who where treated with active endoscopy combined with pharmacological treatment.
format Text
id pubmed-1976099
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-19760992007-09-12 Portal vein thrombosis; risk factors, clinical presentation and treatment Sogaard, Kirstine K Astrup, Lone B Vilstrup, Hendrik Gronbaek, Henning BMC Gastroenterol Research Article BACKGROUND: Portal vein thrombosis (PVT) is increasingly frequently being diagnosed, but systematic descriptions of the natural history and clinical handling of the condition are sparse. The aim of this retrospective study was to describe risk factors, clinical presentation, complications and treatment of portal vein thrombosis in a single-centre. METHODS: Sixty-seven patients were identified in the electronic records from 1992 to 2005. All data were obtained from the patient records. RESULTS: One or more risk factors (e.g. prothrombotic disorder or abdominal inflammation) were present in 87%. Symptoms were abdominalia, splenomegaly, fever, ascites, haematemesis, and weight loss. Abdominalia and fever occurred more frequently in patients with acute PVT. Frequent complications were splenomegaly, oesophageal- and gastric varices with or without bleeding, portal hypertensive gastropathy and ascites. Varices and bleeding were more frequent in patients with chronic PVT. Patients who received anticoagulant therapy more frequently achieved partial/complete recanalization. Patients with varices who were treated endoscopically in combination with β-blockade had regression of the varices. The overall mortality was 13% in one year, and was dependent on underlying causes. CONCLUSION: Most patients had a combination of local and systemic risk factors for PVT. We observed that partial/complete recanalization was more frequent in patients treated with anticoagulation therapy, and that regression of varices was more pronounced in patients who where treated with active endoscopy combined with pharmacological treatment. BioMed Central 2007-08-15 /pmc/articles/PMC1976099/ /pubmed/17697371 http://dx.doi.org/10.1186/1471-230X-7-34 Text en Copyright © 2007 Sogaard et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sogaard, Kirstine K
Astrup, Lone B
Vilstrup, Hendrik
Gronbaek, Henning
Portal vein thrombosis; risk factors, clinical presentation and treatment
title Portal vein thrombosis; risk factors, clinical presentation and treatment
title_full Portal vein thrombosis; risk factors, clinical presentation and treatment
title_fullStr Portal vein thrombosis; risk factors, clinical presentation and treatment
title_full_unstemmed Portal vein thrombosis; risk factors, clinical presentation and treatment
title_short Portal vein thrombosis; risk factors, clinical presentation and treatment
title_sort portal vein thrombosis; risk factors, clinical presentation and treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1976099/
https://www.ncbi.nlm.nih.gov/pubmed/17697371
http://dx.doi.org/10.1186/1471-230X-7-34
work_keys_str_mv AT sogaardkirstinek portalveinthrombosisriskfactorsclinicalpresentationandtreatment
AT astruploneb portalveinthrombosisriskfactorsclinicalpresentationandtreatment
AT vilstruphendrik portalveinthrombosisriskfactorsclinicalpresentationandtreatment
AT gronbaekhenning portalveinthrombosisriskfactorsclinicalpresentationandtreatment